Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC

Clinical trial NCT07500220 · RECRUITING

Trial details

NCT number: NCT07500220
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma (HCC)Metastatic Liver Cancer

Start date: 2026-03-02
Primary completion: 2027-03-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.